Similar results were obtained in a mouse melanoma model (157), in which the combination of PTT mediated by magnetite cationic liposomes, IL-2, and granulocyte macrophage colony-stimulating factor significantly enhanced the antitumor immune response, dramatically reduced tumor burden, and increased survival compared to monotherapy. The gene discussed is IL2; the disease is neoplasm.